Objectives: Performance of an abutment-level superpower sound processor for bone-anchored hearing, the Ponto 3 SuperPower from Oticon Medical (BCD2), was compared to an earlier model from Oticon Medical (BCD1).
maximum force output, relevant for mid-and high-level inputs, results in a clear preference for BCD2 over BCD1.
| INTRODUCTION
For patients with a severe-to-profound mixed hearing loss consisting of a mild-to-moderate sensorineural loss and a substantial air-bone gap, a percutaneous, direct-drive, bone conduction device (BCD) might be a viable alternative to using conventional hearing aids. In cases with therapy-resistant chronic otitis and/or a contraindication for occluding the ear canal or anomalies of ear canal and/or pinna with troublesome ear mould retention, a BCD is preferred over a conventional hearing aid.
The heart of a percutaneous BCD is a titanium implant (fixture) anchored in the skull with a skin-penetrating abutment. The abutment holds a sound processor that converts sound into mechanical vibration. Vibrations generated by the sound processor are transferred directly through abutment and implant to the skull. With this percutaneous type of stimulation, vibrations are not damped by skin and underlying tissue, leading to a 10-15 dB more efficient vibration transmission for the mid and high frequencies than with conventional, transcutaneous, stimulation through an intact skin. 1, 2 The amount of vibration energy required to reach the threshold level for normal hearing when stimulating through direct bone conduction (RETFL dbc ) 3 is much higher than its equivalent for air conduction stimulation (RETSPL). 4 Snik 5 estimates that direct bone conduction stimulation is about 35 dB less efficient than air conduction stimulation. For obtaining equivalent sensation levels for air and bone conduction, 35 dB more power is needed when stimulating through direct bone conduction than with air conduction. So, much more power is needed for producing sounds with direct bone conduction than with air conduction. As the maximum power (force) output is quite limited with a standard BCD, producing loud sounds is troublesome with such a device. In other words, the aided dynamic range of a standard BCD is rather limited. 5, 6 Therefore, in many cases, including those with relatively favourable bone conduction thresholds, a superpower device may be advantageous for undistorted reproduction of loud sounds relative to a less powerful device.
We evaluated the performance of the recently introduced Ponto 3
SuperPower sound processor (BCD2) from Oticon Medical AB (Askim, Sweden) to that of an earlier, less powerful, model with the same form factor, Ponto Pro Power (BCD1) in a group of 20 patients with a severe mixed hearing loss and extensive experience with BCD1. The evaluation involved both clinical measures and questionnaires probing real-life experiences. This study will focus on the effects of the higher maximum force output of the BCD2 in order to corroborate and to extend the findings of an earlier study. 7 We will also focus on differences in the directionality systems of BCD1 and BCD2. For low-level sounds, BCD1 uses a surround microphone mode, that is equal sensitivity for sounds coming from all directions, whereas for this condition BCD2 uses a "speech omni" mode with omni-directional sensitivity for frequencies up to 1880 Hz and full directionality for the higher frequencies. For mid-and high-level sounds, both BCD1 and BCD2 use split-focus and full-focus directionality, respectively. The "speech omni"
mode of BCD2 may be beneficial in many low-level listening situations. We will test this option with speech and noise coming from different locations. Another feature of BCD2 is its wireless connectivity.
We did not study the efficacy of this feature as this was already addressed in an earlier study. 
| MATERIALS AND METHODS
We selected twenty patients from our clinic files that were eligible for a 5-year replacement of their powerful sound processor. Figure 1A . Figure 1A shows that at frequencies above 1 kHz, the MFO of BCD2 is about 10 dB higher than for BCD1. Figure 1B shows the data of Figure 1A in relation to the thresholds for direct bone conduction. 3 The data in Figure 1B were obtained by subtracting the RETFL dbc data in Table II (least squares estimate) in Carlsson et al. 3 from the MFO values in Figure 1A .
A test design with two sessions was used with each patient serving as its own control. At the beginning of the first session, the data logging of each patient's BCD1 was read out for inspection of device use and relative use of its directional modes. In our clinical measurements, we used a new BCD1 to avoid "wear and tear" issues that might appear by long-term device usage. All device settings, except the directionality and noise reduction settings, were copied from the patient's BCD1 into this new BCD1 device. In the clinical measurements, the directionality system of the new BCD1 was fixed for all input levels to surround and noise reduction was switched off to avoid interference with the detection of noise bands and the speech-in-noise measurements.
The low-level gain settings of BCD1 were checked by measuring free-field detection thresholds with 1/3 octave noise bands and by measuring speech perception in quiet with CVC monosyllables. 9 Phoneme scores were measured at 10 dB level intervals, and speech reception thresholds (SRTs) in quiet were estimated by interpolation.
Speech perception in noise was tested with sentence material. 10 The sentences contain 8 or 9 syllables, and they are representative of everyday Dutch. SRTs in noise were estimated using a simple "one up, one down" adaptive procedure 10,11 with 2 dB level steps.
The SRTs were obtained for speech and noise presented from the front at 0°azimuth, the S 0 N 0 condition, and for speech from the front and three identical noise sources at +90°, À90°and 180°azi-muth, the S 0 N À90,+90,180 condition.
Real-life experiences with BCD1 were probed with the APHAB questionnaire 12 and with the SSQ questionnaire. 13 At the end of the first session, BC in situ thresholds were measured with BCD2 using standard Hughson-Westlake "5-up, 10-down" procedures. Similar to the original fitting of BCD1, the BC in situ thresholds were used to program BCD2 with the default settings of the manufacturer's fitting software. In most cases, gain settings for BCD1 and BCD2 were identical. For three patients, the gain of BCD2 was increased manually as they judged soft and conversational speech too soft.
After a 4-week acclimatisation period, free-field aided thresholds, speech intelligibility in quiet and in noise was measured in the clinic for BCD2 with its directionality system fixed to speech omni mode and noise reduction switched off. During the experiments, the wireless accessories for BCD2 were not available. Real-life listening experiences were recorded with APHAB and SSQ questionnaires, but now for the 4-week period with BCD2. Finally, for various listening conditions, device preferences were recorded with a proprietary questionnaire.
In this study, statistical significance was set at P < .05 with Bonferroni corrections to correct for post hoc multiple testing. For significant differences, Cohen's 14 effect size d will be shown.
| RESULTS
Pure-tone thresholds were measured with standard procedures and equipment (Equinox audiometer fitted with TDH39 headphones and B71 bone conductor; Interacoustics, Assens, Denmark). Figure 2 shows the distribution of the unaided pure-tone thresholds for air SRTs for the S 0 N 0 condition were as expected not significantly different for both devices (P > .05). However, in the S 0 N À90,+90,180 condition, the SRT for BCD2 was 1.7 dB lower (more favourable) than for BCD1 (P < .05; effect size 0.64), corresponding to a 25% increase in sentence score. The results for the SSQ questionnaire 13 are shown in Figure 5a b. For all three domains, the scores are significantly higher, that is more favourable, for BCD2 than for BCD1 (P < .01) with effect sizes of 1.22, 0.71 and 1.05, respectively. We also analysed the SSQ data with the four factors found by Akeroyd et al. 15 Their analysis of a large set of SSQ data revealed the following underlying factors:
speech understanding (SU), spatial (SP), clarity, separation and identi- found for the speech understanding (SU) factor score (P < .01). F I G U R E 5 A, Scores for BCD1 and BCD2 for the speech, spatial and qualities of hearing domains of the SSQ questionnaire. 13 All domain scores are significantly higher, more favourable, for BCD2 than for BCD1 (p < 0.01: **). B, SSQ factor scores 15 for BCD1 and BCD2 for speech understanding (SU), spatial (SP), clarity, separation and identification (CSI), and listening effort and concentration (EC). All factor scores are significantly higher, more favourable, for BCD2 than for BCD1 (SU: p < 0.01, **; SP, CSI, EC: p < 0.05, *)
Device preferences were probed with a proprietary questionnaire. Figure 6 shows device preferences when having a conversation in small group and in a large group, when listening to music and overall preference. For conversations in a small group, 16 patients prefer BCD2 over BCD1 and two patients have no preference for either device. In a large group, one patient prefers BCD1, six patients have no preference, and eleven patients prefer BCD2.
When listening to music, all patients prefer BCD2 over BCD1, with a strong preference for BCD2 for seven patients. When asked for an overall preference, all patients prefer BCD2 over BCD1, with nine patients strongly preferring BCD2.
At the end of the experiments, all patients indicated that they wanted to keep BCD2. In addition to BCD2, they received a streamer and a wireless accessory of choice, in almost all cases a TV adaptor.
In the Appendix 1, the results of the speech-in-noise test and the APHAB and SSQ questionnaires are summarised in numerical form.
| DISCUSSION
A limitation of this study is that all patients used BCD1 and BCD2 in Results for the speech and noise frontal condition are not significantly different for BCD1 and BCD2 (P > .05). However, for the condition with frontal speech and three identical noise sources at +90°, À90°and 180°azimuth, the SRT for BCD2 is 1.7 dB (P < .05) lower than for BCD1 (Figure 3 ). This shows that the "speech omni" mode in BCD2 can be more effective over the omni-directional mode of BCD1 when listening to speech in background noise.
The score for the BN domain of the APHAB questionnaire (Figure 4) is significantly lower, more favourable, for BCD2 than for BCD1 (P < .01). Also, the factor score for speech understanding (SU) with the SSQ questionnaire was significantly higher (P < .01) for BCD2 than for BCD1 with scores of 5.2 and 3.3, respectively. This is consistent with the subjective preference for BCD2 over BCD1 when listening in a small group ( Figure 6 ). These favourable results for BCD2 over BCD1 can be related to the new "speech omni" mode incorporated in BCD2.
For frequencies above 1 kHz, maximum force output (MFO) of BCD2 is about 10 dB higher than for BCD1. The advantage of a higher MFO is an increase in aided dynamic range and a reduced need for (high-level) compression. In general, the drawback of a high MFO is that loud inputs may become uncomfortably loud. However, this study shows that the differences in MFO between BCD1 and BCD2 had no significant effect (P > .05) on the score for the aversiveness of loud sounds of the APHAB questionnaire ( Figure 4 ). This corroborates the results of an earlier study. 7 Apparently, the increase in MFO does not elicit aversive sensations when listening to loud sounds. This result was to be expected as the MFO of BCD2 is still below the (estimated) loudness discomfort level of normal listeners. 5 The differences with the SSQ for BCD1 and BCD2 for the spatial factor score (SP) are most likely attributable to MFO differences, as 
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| 1023 both devices were set to (almost) the same gain characteristics and the automatics of the directionality system is similar for BCD1 and BCD2. Figure 6 shows a preference for BCD2 when listening to speech in a large group and when listening to music. This suggests that an increase in maximum force output, and thus in aided dynamic range is advantageous indeed for this patient group.
Expressing maximum output force level relative to the normal threshold for direct bone conduction, that is MFO -/-RETFL dbc , clearly reveals that the output dynamic range of most bone conduction devices is indeed quite limited. 5 This is especially true for standard devices with their relatively low MFO. In a bone conduction device with a high MFO, less compression is needed when reproducing high-level inputs, resulting in a higher fidelity of loud sounds.
This will be especially relevant when participating in relatively loud conversations in a large group or in a noisy environment, for perceiving distance and spatial information and when listening to (live) music. So, in most cases, the sound of a superpower device will be preferred over that of a less powerful device.
In conclusion, the combination of an improved directionality for primarily low-level inputs and a higher maximum force output, relevant for mid-and high-level inputs, results in a clear preference for BCD2 over BCD1. 
